} Research and Innovation Center
Loading...
Announcement:

28 Jul 2021 The Department of Health is pleased to announce the successful completion of the 11th cycle of TANSEEQ Program for medical interns, residents and fellows for the year 2021, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

The Department of Health (DOH) is pleased to announce the central Fellowship Application process for medical graduates, for more information Click Here


RESEARCH AND INNOVATION
CENTER

Abu Dhabi Healthcare Sector has the
potential to deliver high quality Medical
Research and Innovation

RESEARCH AND INNOVATION DASHBOARD

VISION

“To be a leading regional center for healthcare & life-science research & innovation for a healthier population”

Mission

“To develop and sustain thriving research
and innovation ecosystem, across invention, evidence generation and adoption for the regulated products and solutions to position Abu Dhabi as a regional hub for better healthcare outcomes, knowledge, and socioeconomic prosperity”

Values

Public-Centered
Transparency
Innovation
& Excellence
Agility
Synergy

PRIORITIES

Department of Health has strategized key priorities that underpin the goal of improving the well-being of Abu Dhabi residents through prevention and access to integrated, innovative, high-quality and cost-effective healthcare. Genomic medicine is a ground-breaking genomics initiative that involves using genomic information about an individual to understand genetics bases, provide accurate diagnosis and treatment and implement precision medicine. A healthier Abu Dhabi community will not be achieved expediently unless innovation and research are at the core of its daily business.

Priority Disease

  • Cancer and Rare Disease
  • Cardiovascular Disease (Obesity, Diabetes, Hypertension, Smoking …etc)
  • Chronic Respiratory Disease
  • Emerging Infectious Disease & Antimicrobial Resistance
  • Injuries and Occupational Health
  • Mental Health Behavioral, and Neurodevelopment Disorders
  • Woman and Child Health (Reproductive, Maternal, Newborn, Child Health, and Developmental Diseases)

Areas of Research

  • Big Data
  • Internet of Medical Things (IOMT)
  • Precision Medicine
  • Assistive Technology
  • Drug Discovery
  • Discovery Science
  • Advanced Therapies (cell therapies, implantable devices, robotics, etc)
  • Nano-Medicine
  • Biomedicine
  • Public Health/Prevention
  • Genetic and Epigenetics

Research and Innovation
Programs

Publications

Resource

Medical Research and Development

This applies to all entities who are interested in conducting a human subject research in Abu Dhabi such as:

  • Healthcare facilities
  • Academic institutes
  • Contract Research
    Organizations (CRO’s)
  • Government/Private
    institutes

01.

Facilities should form a local Research Ethics Committee in order to submit their application to us

02.

Follow the below requirements

03.

Once approved, research authorization will be granted

04.

Facility name will appear on the list of facilities approved to carry out human subject research

Authorized Institutions

Requirements

  1. Application for Authorization to Conduct Human Subjects Research
  2. Research Ethics Committee (REC) members list
    - Including CVs and DOH health license if applicable
  3. Research Ethics Training Course For all ethics committee members
  4. DOH Undertaking letter
    - Signed by all REC members

Directly upload the forms or for any inquiries, email us at medical.research@doh.gov.ae

Maximum file size is 8 MB

Organizations and researchers who are interested in conducting human subject research in the below streams, are welcomed to apply directly to DOH Medical Research Team

  • Clinical Trials
  • Multi-centers
  • Genomics
  • Processing of medical data outside UAE,
  • Pharmaceutical/companies sponsored research, and Academic sponsored research.
  • Others (COVID, etc)

Research proposals for the above streams will be evaluated by DOH ADHRTC (Abu Dhabi Research and Technology Committee)

01.

Click here to download application form

Application form

02.

Send your application form and all the required documents (Detailed proposal- Research team CVs and GCPs- Data collection Sheet- Questionnaire/Survey- Consent Form) to Medical Research team at medical.research@doh.gov.ae

03.

ADHRTC Committee will review the application

04.

Final outcome letter will be shared

05.

Browse the Research Registry

Research Registry

For any inquiries, email : medical.research@doh.gov.ae

INNOVATION SERVICES

Health technology assessment (HTA) refers to the systematic evaluation of properties, effects, and/or impacts of health technology.

01.

Submit HTA application (please find the forms and documents below)

02.

Once received, an evaluation process will take place based on safety, efficiency and effectiveness

03.

An Official letter will be sent to applicants (Approved or Disapproved)

04.

Codes/pricing, product/therapy registration and publication

05.

Browse the Technology Registry

Technology Registry

Fill the forms and email us at adhtac@doh.gov.ae

Maximum file size is 8 MB

For disapproval decisions: HTA applicants appealing submission to adhtac@doh.gov.ae
(Within 30 days of receiving disapproval decision) to start the same journey.

Shape the future of healthcare through innovation. HealthTech Hub offers a comprehensive support network for the testing, implementation and commercialization of health technologies.

01.

Initial interview & meeting of startups

02.

Startup submission of business plan and requirements for ecosystem support

03.

Agreement of joint project plan and timeline

04.

Startups application of ADGM Tech License

05.

DoH support in regulation, Proof of Concept Design, Coaching, Access to Investor Networks, Access to Partners and Health Technology Assessment

06.

Graduation from DoH HealthTech program (maximum 24 months)

For any inquiries, email us at: HealthTech@doh.gov.ae

Drug and Medical Products

Through this service, as drug agents and healthcare providers (hospitals), you can apply to code drugs, including conventional and general sale products. These codes are essential for drug product reimbursement by insurance and applicants can apply to amend coded drug details.

01

Submit the application and all required documents through TAMM portal

TAMM portal

02.

Receive DoH’s approval, rejection or request for additional details

03.

Obtain the drug code.

Required Documents:

  1. MOH Drug/Product Registration Certificate; From the Ministry of Health and Prevention for registered drugs (drug agents)
  2. MOH Price Certificate; From the Ministry of Health and Prevention for registered drugs (drug agents)
  3. Price Quotation; For non-registered drugs (hospitals)
  4. Good Manufacturing Practice (GMP) Certificate; For non-registered drugs (hospitals)
  5. Artwork/Product Image
  6. Product Image
  7. Product Leaflet

For any inquiries, email : drugcodes@doh.gov.ae

Through this service, you can apply for laboratory analysis of any medical product, such as pharmaceuticals, dietary supplements, herbal or cosmetic products to ensure the absence of any dangerous substances and that it is safe for use.

Conditions
The applicant must hand in the sample in person.

01

Applicants to submit form and required documents through TAMM portal

TAMM portal

02.

Submit the sample of the product At the Department of Health counter

03.

Obtain the results from DoH through SMS or a phone call, if needed

For any inquiries, email : drugcodes@doh.gov.ae

Through this service, healthcare facilities in Abu Dhabi may apply to assign or replace a person that is responsible for narcotics and controlled drugs

01

Applicants to submit form and required documents through TAMM portal

TAMM portal

02.

Once received, an evaluation process will take place

03.

Receive the approved electronic application form

Required Documents:

  1. Application Form; Complete and sign the “Approving a person to be responsible for narcotics and controlled drugs” form
  2. Official Letter From the Medical Director to authorize the current person in-charge
  3. Signed handover Report on Controlled and Narcotic Drugs; in case of changing responsible person

For any inquiries, email : cdreport@doh.gov.ae

Through this service, Facility’s Narcotic in-charge should submit the consumption report for controlled drugs on a monthly basis and quarterly for narcotic drugs.

Process and required documents:

  1. Click here to download the report form.
  2. Send the filled report to DoH through e-mail address:  cdreport@doh.gov.ae

For any inquiries, email : cdreport@doh.gov.ae

Through this service, Facility’s Narcotic in charge should report to DoH any lost/broken ampoules; or any narcotic or controlled drugs incidences.

Process and required documents:

  1. Click here here to download the Narcotic/ Controlled Drug Incident Report Form.
  2. Enclose and submit the required documents as required.
  3. Send the form to DoH Narcotic officer within 48 hours through e-mail address:  cdreport@doh.gov.ae

Through this service you can access the unified electronic platform approved at the country level for prescribing and dispensing of narcotic, controlled and semi controlled medicines.
The federal law obligates all healthcare facilities and providers to use the system for prescribing and dispensing narcotic, controlled and semi-controlled medicines. Also, all licensed healthcare facilities and pharmacies must provide Emirates ID card reader to all their physicians and pharmacists who are dealing with narcotic and controlled medicines.

Follow the steps in the link below for both on-boarding your facility along with a healthcare provider registration steps:

  1. For further clarification or technical assistance email:  cm_support@inhealth.ae

    telephone: 800-37847
  2. Click here for further information on the platform

Through this service, concerned stakeholders including hospitals, pharmacies and drug suppliers are required to report all anticipated and /or actual drug shortages to DOH immediately in order to avert and mitigate the problem.

Process:

  1. Click here to download the Drug Shortage Reporting Form.
  2. Send the Reporting Form through e-mail address:  drugshortage@doh.gov.ae

DoH will work closely with the drug suppliers, manufacturers & health care facilities to identify root causes of the reported shortages and fill any gaps in the supply chain to ensure ease of access and availability of necessary medicines to all residents of Abu Dhabi.

Through this service, healthcare professionals can report any suspected Adverse Reaction (AR), Medication Error (ME) and Adverse Event Following Immunization (AEFI) experienced from any of the drug product within the stipulated timeframe as defined in DoH policies, even if reporters are not certain that the particular medicinal product was the cause. Unintended adverse effects, drug abuse, overdose, interaction (including drug-drug and drug-food interactions) and unusual lack of therapeutic efficacy are all considered to be reportable suspected Adverse Reactions (AR).

01

Click to access the e-Notification system

E-Notification

02.

Log in using your professional or facility account information

03.

Select notification then Pharmacovigilance then select type of report

04.

Fill out all the required information

05.

Click ‘’Submit “

For any enquiries send an email to:  pharmacovigilance@doh.gov.ae

Through this service Healthcare facilities are required to submit their antidote stock report on monthly basis . The service allows the hospital user to report the stock of antidote by the 5th of each month.

Process:

  1. Click the here to access the e-Notification system.
  2. Log in using your professional or facility account information.
  3. Select notification then Antidote Monthly Stock Report.
  4. The Antidote Monthly Stock Report Form will be displayed to be filled by user.

For enquiries e-mail to  antidotes@doh.gov.ae

Subscribe for updates

Thanks for Subscribing

Mobile For an optimal experience please
rotate your device to portrait mode